United States · FDA National Drug Code directory
NEVIRAPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-131_41535937-97d5-fb3f-e063-6294a90afa9e
- Product NDC
- 42571-131
- Form
- TABLET
- Composition / generic term
- NEVIRAPINE
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120522
- Source listing expiry
- 20261231
Source-listed ingredients
- NEVIRAPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (42571-131-29) / 10 TABLET in 1 BLISTER PACK · 42571-131-29
- 60 TABLET in 1 BOTTLE (42571-131-60) · 42571-131-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →